These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7336930)

  • 1. The effect of serum and plasma from haemodialysis patients on human mononuclear phagocytes cultured in vitro.
    Wessel-Aas T
    Acta Pathol Microbiol Scand C; 1981 Dec; 89(6):345-51. PubMed ID: 7336930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of uraemic serum and plasma on proliferating cells in vitro.
    Wessel-Aas T
    Acta Pathol Microbiol Scand C; 1981 Dec; 89(6):353-8. PubMed ID: 6950656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of plasma from uraemic patients on human mononuclear phagocytes cultured in vitro.
    Jorstad S; Viken KE
    Acta Pathol Microbiol Scand C; 1977 Jun; 85(3):169-77. PubMed ID: 327752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids.
    Wessel-Aas T; Blomhoff JP; Wirum E; Nilsen T
    Acta Med Scand; 1984; 216(1):75-83. PubMed ID: 6485883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro.
    Jörstad S; Kvernes S
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):221-6. PubMed ID: 362814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal lipoprotein in uraemic patients treated conservatively and by maintenance haemodialysis.
    Alam SM; Bhatt AK
    J Assoc Physicians India; 1991 Feb; 39(2):170-1. PubMed ID: 1885478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis.
    Bakaev VV; Efremov AV; Tityaev II
    Nephrol Dial Transplant; 1999 Jun; 14(6):1472-4. PubMed ID: 10383010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.
    Remuzzi G; Livio M; Marchiaro G; Mecca G; de Gaetano G
    Nephron; 1978; 22(4-6):347-53. PubMed ID: 740096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.
    Trelewicz P; Grzeszczak W; Drabczyk R
    Int Urol Nephrol; 1994; 26(1):117-23. PubMed ID: 8026916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma histamine levels in uraemic pruritus.
    Stockenhuber F; Kurz RW; Sertl K; Grimm G; Balcke P
    Clin Sci (Lond); 1990 Nov; 79(5):477-82. PubMed ID: 2174315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidaemia in uraemic patients under chronic haemodialysis. Correlation with serum lipoprotein lipase and insulin levels.
    Sobh MA; Shamaa SA; el-Gayar AM; el-Sharabacy MM
    Int Urol Nephrol; 1989; 21(6):667-74. PubMed ID: 2700187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrine.
    Nenci GG; Berrettini M; Agnelli G; Parise P; Buoncristiani U; Ballatori E
    Nephron; 1979; 23(6):287-92. PubMed ID: 384281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of haemodialysis on the antibody-dependent and spontaneous cell-mediated cytotoxicity of patients with chronic renal failure.
    Láng I; Taraba I; Hering A; Petrányi G
    Immunol Lett; 1982 Jul; 5(1):55-8. PubMed ID: 7118188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients.
    Cohen G; Rudnicki M; Schmaldienst S; Hörl WH
    Nephrol Dial Transplant; 2002 May; 17(5):879-83. PubMed ID: 11981077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased concentrations of serum phospholipid plasmalogens indicate oxidative burden of uraemic patients undergoing haemodialysis.
    Brosche T; Platt D; Knopf B
    Nephron; 2002 Jan; 90(1):58-63. PubMed ID: 11744806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes.
    Herbelin A; Ureña P; Nguyen AT; Zingraff J; Descamps-Latscha B
    Nephrol Dial Transplant; 1991; 6(5):349-57. PubMed ID: 1870752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fibronectin on C3b and Fc receptor-mediated phagocytosis by peripheral blood monocytes in uraemic patients.
    Pertosa G; Mastrolitti G; Späth PJ; Fracasso AR; Manno C; Schena FP
    Nephrol Dial Transplant; 1989; 4(1):15-20. PubMed ID: 2522602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.